{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:01:52Z","timestamp":1786946512776,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Wolfram syndrome (WFS) is a rare, neurodegenerative disease that typically presents with childhood onset insulin dependent diabetes mellitus, followed by optic atrophy, diabetes insipidus, deafness, and neurological and psychiatric dysfunction. There is no cure for the disease, but recent advances in research have improved understanding of the disease course. Measuring disease severity and progression with reliable and validated tools is a prerequisite for clinical trials of any new intervention for neurodegenerative conditions. To this end, we developed the Wolfram Unified Rating Scale (WURS) to measure the severity and individual variability of WFS symptoms. The aim of this study is to develop and test the reliability and validity of the Wolfram Unified Rating Scale (WURS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A rating scale of disease severity in WFS was developed by modifying a standardized assessment for another neurodegenerative condition (Batten disease). WFS experts scored the representativeness of WURS items for the disease. The WURS was administered to 13 individuals with WFS (6-25 years of age). Motor, balance, mood and quality of life were also evaluated with standard instruments. Inter-rater reliability, internal consistency reliability, concurrent, predictive and content validity of the WURS were calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The WURS had high inter-rater reliability (ICCs&gt;.93), moderate to high internal consistency reliability (Cronbach\u2019s \u03b1 = 0.78-0.91) and demonstrated good concurrent and predictive validity. There were significant correlations between the WURS Physical Assessment and motor and balance tests (r<jats:sub>s<\/jats:sub>&gt;.67, p&lt;.03), between the WURS Behavioral Scale and reports of mood and behavior (r<jats:sub>s<\/jats:sub>&gt;.76, p&lt;.04) and between WURS Total scores and quality of life (r<jats:sub>s<\/jats:sub>=-.86, p=.001). The WURS demonstrated acceptable content validity (Scale-Content Validity Index=0.83).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These preliminary findings demonstrate that the WURS has acceptable reliability and validity and captures individual differences in disease severity in children and young adults with WFS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-1172-7-89","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T01:14:22Z","timestamp":1352855662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Reliability and validity of the Wolfram Unified Rating Scale (WURS)"],"prefix":"10.1186","volume":"7","author":[{"given":"Chau","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin R","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R","family":"Paciorkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Viehoever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Considine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidena","family":"Bondurant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bess A","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Hershey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Washington University Wolfram Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,14]]},"reference":[{"issue":"8988","key":"489_CR1","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/S0140-6736(95)92473-6","volume":"346","author":"TG Barrett","year":"1995","unstructured":"Barrett TG, Bundey SE, Macleod AF: Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995, 346 (8988): 1458-1463. 10.1016\/S0140-6736(95)92473-6.","journal-title":"Lancet"},{"issue":"1","key":"489_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/JPEM.2009.22.1.3","volume":"22","author":"MA Ganie","year":"2009","unstructured":"Ganie MA, Bhat D: Current developments in wolfram syndrome. J Pediatr Endocrinol Metab. 2009, 22 (1): 3-10.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"489_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1399-5448.2009.00518.x","volume":"11","author":"S Kumar","year":"2010","unstructured":"Kumar S: Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists. Pediatr Diabetes. 2010, 11 (1): 28-37. 10.1111\/j.1399-5448.2009.00518.x.","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"489_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1212\/01.wnl.0000169019.41332.8a","volume":"65","author":"FJ Marshall","year":"2005","unstructured":"Marshall FJ, de Blieck EA, Mink JW, Dure L, Adams H, Messing S, et al: A clinical rating scale for Batten disease. Neurology. 2005, 65 (2): 275-10.1212\/01.wnl.0000169019.41332.8a.","journal-title":"Neurology"},{"issue":"2","key":"489_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"H Kremer","year":"1996","unstructured":"Kremer H: Unified Huntington's disease rating scale: reliability and consistency. Mov Disord. 1996, 11 (2): 136-142.","journal-title":"Mov Disord"},{"issue":"1","key":"489_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mds.870090112","volume":"9","author":"P Martinez-Martin","year":"1994","unstructured":"Martinez-Martin P, Gil-Nagel A, Gracia LM, G\u00f3mez JB, Mart\u00ednez-Sarri\u00e9s J, Bermejo F: Unified Parkinson's disease rating scale characteristics and structure. Mov Disord. 1994, 9 (1): 76-83. 10.1002\/mds.870090112.","journal-title":"Mov Disord"},{"issue":"20","key":"489_CR7","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1212\/WNL.0b013e3182377e29","volume":"77","author":"J Cialone","year":"2011","unstructured":"Cialone J, Augustine E, Newhouse N, Vierhile A, Marshall F, Mink J: Quantitative telemedicine ratings in Batten disease. Neurol. 2011, 77 (20): 1808-1811. 10.1212\/WNL.0b013e3182377e29.","journal-title":"Neurol"},{"issue":"7","key":"489_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1469-8749.2010.03628.x","volume":"52","author":"HR Adams","year":"2010","unstructured":"Adams HR, Beck CA, Levy E, Jordan R, Kwon JM, Marshall FJ, et al: Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease). Dev Med Child Neurol. 2010, 52 (7): 637-643. 10.1111\/j.1469-8749.2010.03628.x.","journal-title":"Dev Med Child Neurol"},{"issue":"20","key":"489_CR9","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1212\/WNL.0b013e318237f649","volume":"77","author":"J Kwon","year":"2011","unstructured":"Kwon J, Adams H, Rothberg P, Augustine E, Marshall F, Vierhile A, et al: Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurol. 2011, 77 (20): 1801-1807. 10.1212\/WNL.0b013e318237f649.","journal-title":"Neurol"},{"key":"489_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10545-011-9421-6","volume":"35","author":"J Cialone","year":"2012","unstructured":"Cialone J, Adams H, Augustine EF, Marshall FJ, Kwon JM, Newhouse N, et al: Females experience a more severe disease course in batten disease. J Inherit Metab Dis. 2012, 35: 549-555. 10.1007\/s10545-011-9421-6.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"489_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10545-011-9346-0","volume":"34","author":"J Cialone","year":"2011","unstructured":"Cialone J, Augustine EF, Newhouse N, Adams H, Vierhile A, Marshall FJ, et al: Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data. J Inherit Metab Dis. 2011, 34 (5): 1075-1081. 10.1007\/s10545-011-9346-0.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"489_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/87565640701361013","volume":"32","author":"JC Gidley Larson","year":"2007","unstructured":"Gidley Larson JC, Mostofsky SH, Goldberg MC, Cutting LE, Denckla MB, Mahone EM: Effects of Gender and Age on Motor Exam in Typically Developing Children. Dev Neuropsychol. 2007, 32 (1): 543-562. 10.1080\/87565640701361013. 2007\/07\/06","journal-title":"Dev Neuropsychol"},{"issue":"4","key":"489_CR13","first-page":"773","volume":"21","author":"MB Denckla","year":"1985","unstructured":"Denckla MB: Revised Neurological Examination for Subtle Signs (1985). Psychopharmacol Bull. 1985, 21 (4): 773.","journal-title":"Psychopharmacol Bull"},{"issue":"4","key":"489_CR14","first-page":"323","volume":"42","author":"F Franchignoni","year":"2010","unstructured":"Franchignoni F, Horak F, Godi M, Nardone A, Giordano A: Using psychometric techniques to improve the Balance Evaluation System\u2019s Test: the mini-BESTest. J Rehabil Med Offic J UEMS Eur Board Phys Rehabil Med. 2010, 42 (4): 323.","journal-title":"J Rehabil Med Offic J UEMS Eur Board Phys Rehabil Med"},{"issue":"8","key":"489_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1542\/pir.21-8-265","volume":"21","author":"TM Achenbach","year":"2000","unstructured":"Achenbach TM, Ruffle TM: The Child Behavior Checklist and related forms for assessing behavioral\/emotional problems and competencies. Pediatr Rev. 2000, 21 (8): 265-10.1542\/pir.21-8-265.","journal-title":"Pediatr Rev"},{"issue":"5","key":"489_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0005-7967(98)00034-5","volume":"36","author":"SH Spence","year":"1998","unstructured":"Spence SH: A measure of anxiety symptoms among children. Behav Ther. 1998, 36 (5): 545-566. 10.1016\/S0005-7967(98)00034-5.","journal-title":"Behav Ther"},{"issue":"6","key":"489_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0887-6185(02)00236-0","volume":"17","author":"SH Spence","year":"2003","unstructured":"Spence SH, Barrett PM, Turner CM: Psychometric properties of the Spence Children\u2019s Anxiety Scale with young adolescents. J Anxiety Disord. 2003, 17 (6): 605-625. 10.1016\/S0887-6185(02)00236-0.","journal-title":"J Anxiety Disord"},{"issue":"6","key":"489_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","volume":"3","author":"JW Varni","year":"2003","unstructured":"Varni JW, Burwinkle TM, Seid M, Skarr D: The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003, 3 (6): 329-341. 10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2.","journal-title":"Ambul Pediatr"},{"issue":"5","key":"489_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/nur.20147","volume":"29","author":"DF Polit","year":"2006","unstructured":"Polit DF, Beck CT: The content validity index: Are you sure you know what's being reported? Critique and recommendations. Res Nurs Health. 2006, 29 (5): 489-497. 10.1002\/nur.20147.","journal-title":"Res Nurs Health"},{"issue":"4","key":"489_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/nur.20199","volume":"30","author":"DF Polit","year":"2007","unstructured":"Polit DF, Beck CT, Owen SV: Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007, 30 (4): 459-467. 10.1002\/nur.20199.","journal-title":"Res Nurs Health"},{"issue":"3","key":"489_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(SICI)1098-240X(199706)20:3<269::AID-NUR9>3.0.CO;2-G","volume":"20","author":"JS Grant","year":"1997","unstructured":"Grant JS, Davis LL: Selection and use of content experts for instrument development. Res Nurs Health. 1997, 20 (3): 269-274. 10.1002\/(SICI)1098-240X(199706)20:3<269::AID-NUR9>3.0.CO;2-G.","journal-title":"Res Nurs Health"},{"key":"489_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1477-7525-3-34","volume":"3","author":"JW Varni","year":"2005","unstructured":"Varni JW, Burwinkle TM, Lane MM: Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application. Health Qual Life Outcome. 2005, 3: 34-10.1186\/1477-7525-3-34.","journal-title":"Health Qual Life Outcome"},{"key":"489_CR23","volume-title":"Guidance for industry: qualification process for drug development tools: draft guidance","author":"FDA","year":"2010","unstructured":"FDA: Guidance for industry: qualification process for drug development tools: draft guidance. 2010, Silver Spring, MD: Center for Drug Evaluation and Research"},{"issue":"1","key":"489_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejmg.2010.09.011","volume":"54","author":"S Mathis","year":"2010","unstructured":"Mathis S, Maisonobe T, Neau JP: Neuropathy in Wolfram syndrome. Eur J Med Genet. 2010, 54 (1): 73-75. Jan-Feb","journal-title":"Eur J Med Genet"},{"issue":"3","key":"489_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ana.22160","volume":"69","author":"A Chaussenot","year":"2011","unstructured":"Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, Mkadem SAE, Chabrol B, et al: Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol. 2011, 69 (3): 501-508. 10.1002\/ana.22160.","journal-title":"Ann Neurol"},{"issue":"3","key":"489_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2337\/diacare.26.3.631","volume":"26","author":"JW Varni","year":"2003","unstructured":"Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL: The PedsQL\u2122 in type 1 and type 2 diabetes. Diabetes Care. 2003, 26 (3): 631-637. 10.2337\/diacare.26.3.631.","journal-title":"Diabetes Care"},{"issue":"6","key":"489_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","volume":"3","author":"JW Varni","year":"2003","unstructured":"Varni JW, Burwinkle TM, Seid M, Skarr D: The PedsQL\u2122* 4.0 as a Pediatric Population Health Measure: Feasibility, Reliability, and Validity. Ambul Pediatr. 2003, 3 (6): 329-341. 10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2.","journal-title":"Ambul Pediatr"},{"issue":"2","key":"489_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/016327879601900205","volume":"19","author":"JT Fitzgerald","year":"1996","unstructured":"Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG: Development and validation of the Diabetes Care Profile. Eval Health Prof. 1996, 19 (2): 208-230. 10.1177\/016327879601900205.","journal-title":"Eval Health Prof"},{"issue":"5","key":"489_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005650-199705000-00003","volume":"35","author":"JG Boyer","year":"1997","unstructured":"Boyer JG, Earp JAL: The development of an instrument for assessing the quality of life of people with diabetes: Diabetes-39. Med Care. 1997, 35 (5): 440-10.1097\/00005650-199705000-00003.","journal-title":"Med Care"},{"issue":"7","key":"489_CR30","doi-asserted-by":"publisher","first-page":"e40604","DOI":"10.1371\/journal.pone.0040604","volume":"7","author":"T Hershey","year":"2012","unstructured":"Hershey T, Lugar HM, Shimony JS, Rutlin J, Koller JM, Perantie DC, et al: Early Brain Vulnerability in Wolfram Syndrome. PLoS One. 2012, 7 (7): e40604-10.1371\/journal.pone.0040604.","journal-title":"PLoS One"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-7-89.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:43:36Z","timestamp":1630532616000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-7-89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-7-89","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,14]]},"assertion":[{"value":"12 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"89"}}